JPRN-UMIN000006285已完成未知
The beneficial effect and safety Eldecalcitol with combined peginterferon alpha-2a plus ribavirin for chronic hepatitis C patients with osteoporosis - CHALLENGE A plus trial
Department of Hepatology, Osaka City University0 个研究点目标入组 50 人开始时间: 2016年12月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
Enrolled patients were few. Now, new anti-HCV drugs were available for patients with chronic hepatitis C. We decide the discontinuation of the present study.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients were excluded women of childbearing potential and pregnancy, lactating women allergic to ribavirin or other nucleoside analoges an uncontrollable heart trouble( myocardial infarction, heart failure, or arrhythmia) hemoglobibopathy ( thalassemia, sickle cell disease) severe renal disease or Ccr<50mL/min severe depression or psychosomatic disorders severe liver disease autoimmune hepatitis or HBV drug allegy against interferon allergic to vaccine or biological preperations concomitant herbal medication of Sho-saiko-to history of interstitial pneumonia patients who take active vitamin D3 other than Eldecalcitol other conditions considerd inappropriate by attending physician
研究者
相似试验
已完成
不适用
Adding of sitagliptin phosphate hydrate to combination therapy with pegylated interferon alpha 2b and ribavirin for patients with chronic hepatitis C and diabetes mellitusPatients with chronic hepatitis C and hyperglycemiaJPRN-UMIN000003775Department of Hepatology, Osaka City University50
已完成
不适用
Direct Acting Anti-Viral's In Chronic HCV PatientsSafety IssuesNCT04664894Getz Pharma511
Unknown
4 期
Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral AgentsChronic Hepatitis BNCT02337127Kaohsiung Medical University Chung-Ho Memorial Hospital500
已完成
3 期
Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 InfectionHepatitis C, ChronicCirrhosis, DecompensatedNCT02597166University Health Network, Toronto14
已完成
4 期
EBR/GZR for HCV-1b Patients Receiving HemodialysisHepatitis CNCT03420300National Taiwan University Hospital40